News and debate on nicotine, e-cigs and snus

News

  • Olika vejplagar gav effekt på rökningen i Australien och Nya Zeeland

    Olika vejplagar gav effekt på rökningen i Australien och Nya Zeeland

    Australien och Nya Zeeland har valt diametralt olika vägar kring regleringen av vejpprodukter. Förbud och apoteksförsäljning kontra tillåten försäljning i butiker. Nu har ett forskarlag från institutioner i bägge länderna jämfört tillvägagångssätten och försökt dra slutsatser kring hur det påverkat cigarettrökningen.

  • Public health authority stops sales of 'NoNic' and 'Metatine'

    Public health authority stops sales of 'NoNic' and 'Metatine'

    The Public Health Agency of Sweden is stopping the sale of the nicotine analogue 6-methyl nicotine - known commercially as "NoNik" or "Metatine". The reason is that, in order to be sold, the products must first be registered and labelled under the Tobacco and Similar Products Act.

  • Bulgaria mulls vejp ban - but disposable models at risk

    Bulgaria mulls vejp ban - but disposable models at risk

    The big-smoking country of Bulgaria first voted unanimously in its parliament to ban vejp altogether. Then it realised that the move was against EU law and changed its mind. Now the latest move seems to be to ban single-use vejp instead.

Research

Nicotine analogues take hold in Sweden - an unregulated version of nicotine

Tax-free. Without restrictions on either dose or quantity. The nicotine analogue 6-methyl nicotine or "metatine" has arrived in Sweden and is now sold in several shops as an alternative to nicotine in e-cigarettes and e-liquids. But what exactly is it - and why has a so-called synthetic nicotine analogue made its way into Swedish shops?

Researchers say: "Too many smokers try to quit with ineffective methods"

Studies from the UK show that many smokers still try to quit using ineffective methods. Now researchers are speaking out.
"The likelihood of success increases dramatically if you use evidence-based methods such as vejpning or other nicotine alternatives," says the study's lead author, Sarah Jackson.